Lactose intolerance in irritable bowel syndrome patients with diarrhoea: the roles of anxiety, activation of the innate mucosal immune system and visceral sensitivity

Citations Over TimeTop 10% of 2013 papers

Abstract

IBS-D patients with lactose intolerence are characterised by anxiety, mucosal immune activation and increased visceral sensitivity after lactose ingestion. The presence of these biomarkers may indicate an IBS phenotype that responds to dietary therapy and/or mast cell stabilisers.

Related Papers

• → Medical Therapies for Diarrhea-Predominant Irritable Bowel Syndrome(2021)4 cited
• → Stability of irritable bowel syndrome using a Rome II‐based classification(2005)39 cited
• → Prevalence of Irritable Bowel Syndrome in Chronic Fatigue(1996)57 cited
• Irritable Bowel Syndrome and Relationship Between Emotional Factors Probe(2011)
• → Irritable Bowel Syndrome(2008)8 cited